TMCnet News
European Transcatheter Mitral Valve Replacement Market Report 2017 - Research and MarketsResearch and Markets has announced the addition of the "Transcatheter Mitral Valve Replacement" report to their offering. This report presents a summary of the reimbursement situation for a transcatheter mitral valve replacement for mitral regurgitation. Report includes essential information about reimbursement and national funding of the transcatheter mitral valve replacement for mitral regurgitation, including: - Brief overview of reimbursement system for medical devices - Procedure coding for technology - Diagnosis coding - Payment mechanism for technology - Reimbursement tariffs for technology - Restrictions in indications or scenarios for use of technology - Policy considerations y payers and policy-makers about technology Key Topics Covered: 1. Introduction and summary 2. Executive summary table 3. Contents 4. Methodology 5. Reimbursement analysis in Austria 6. Reimbursement analysis in Belgium 7. Reimbursement analysis in Denmark 8. Reimbursement analysis in England 9. Reimbursement analysis in France 10. Reimbursement analysis in Germany 11. Reimbursement analysis in Italy 12. Reimbursement analysis in the Netherlands 13. Reimbursement analysis in Norway 14. Reimbursement analysis in Sweden 15. Reimbursement analysis in Switzerland Companies Mentioned - Caisson Interventional (Caisson Transcatheter Mitral Valve System) - Edwards Lifesciences (CardiAQ-Edwards Transcatheter Mitral Valve) - HighLife (HighLife transcatheter mitral valve replacement device) - Medtronic (TMV) - MitrAssist - NaviGate Cardiac Structures (NAVI System) For more information about this report visit http://www.researchandmarkets.com/research/542ks7/transcatheter
View source version on businesswire.com: http://www.businesswire.com/news/home/20170522006042/en/ |